Finance

Beta
Lists
603193:SHA
Runben Biotechnology Co Ltd
CN¥22.51
+0.13%
(+0.030) 1D
Jun 5, 3:00:04 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 603193...
Open
CN¥22.44
High
CN¥23.88
Low
CN¥22.42
Mkt. cap
9.10B
Avg. vol.
4.71M
Volume
4.07M
Dividend
2.04%
Quarterly dividend
CN¥0.11
Ex-dividend date
May 29, 2026
P/E ratio
28.20
52-wk high
CN¥42.61
52-wk low
CN¥20.28
EPS
CN¥0.80
No. of employees
1K
Open
CN¥22.44
High
CN¥23.88
Low
CN¥22.42
Mkt. cap
9.10B
Avg. vol.
4.71M
Volume
4.07M
Dividend
2.04%
Quarterly dividend
CN¥0.11
Ex-dividend date
May 29, 2026
P/E ratio
28.20
52-wk high
CN¥42.61
52-wk low
CN¥20.28
EPS
CN¥0.80
No. of employees
1K
News stories
From sources across the web
About Runben Biotechnology Co Ltd
CEO-
Employees1.02K
Founded1993
Headquarters-
SectorPersonal care products
Websiterunben.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
655.08M
342.41M
307.27M
267.09M
Cost of goods sold
276.56M
138.21M
130.24M
109.25M
Cost of revenue
276.56M
138.21M
130.24M
109.25M
Research and development expenses
8.71M
8.74M
12.46M
8.38M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
202.68M
107.83M
126.19M
95.26M
Operating expense
217.74M
116.04M
142.36M
106.00M
Total operating expenses
494.30M
254.26M
272.60M
215.25M
Operating income
160.78M
88.16M
34.67M
51.84M
Other non operating income
-92.22K
-82.64K
96.83K
-78.74K
EBT including unusual items
169.75M
93.42M
48.69M
57.21M
EBT excluding unusual items
171.81M
95.58M
43.53M
56.27M
Income tax expense
26.42M
14.89M
234.06K
4.57M
Effective tax rate
15.56%
15.94%
0.48%
7.99%
Other operating expenses
3.37M
1.92M
4.47M
2.11M
Net income
143.33M
78.52M
48.45M
52.64M
Net profit margin
21.88%
22.93%
15.77%
19.71%
Earnings per share
-
-
-
-
Interest and investment income
11.16M
7.50M
8.73M
4.52M
Interest expense
-21.93K
-18.73K
-15.50K
-12.23K
Net interest expenses
11.14M
7.48M
8.71M
4.51M
Depreciation and amortization charges
-
-
-
-
EBITDA
166.09M
93.06M
39.81M
56.98M
Gain or loss from assets sale
-80.15K
80.15K
-80.39K
-
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more